CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | HENRIQUES RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-06-01 | Brun Scott C. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-05-19 | Binder Gwendolyn See Remarks | Option exercise 10b5-1 | +22,000 | $1.01 | $22K | 42,000 |
| 2023-05-19 | Binder Gwendolyn See Remarks | Sale 10b5-1 | −22,000 | $11.81 | $260K | 20,000 |
| 2023-05-19 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −22,000 | 188,756 | ||
| 2023-01-18 | Nichtberger Steven President & CEO | Grant or award · Stock Option (Right to Buy) | +411,600 | 411,600 | ||
| 2023-01-18 | Gerard Michael General Counsel | Grant or award · Stock Option (Right to Buy) | +112,500 | 112,500 | ||
| 2023-01-18 | Das Arun Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-01-18 | Binder Gwendolyn See Remarks | Grant or award · Stock Option (Right to Buy) | +176,000 | 176,000 | ||
| 2023-01-18 | Chang David J. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-01-18 | Marda Anup Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-10-19 | Nichtberger Steven President & CEO | Purchase | +8,127 | $1.25 | $10K | 986,483 |
| 2022-10-18 | Bollard Catherine Director | Purchase | +1,000 | $0.99 | $994 | 1,000 |
| 2022-10-18 | Marda Anup Chief Financial Officer | Purchase | +50,000 | $0.99 | $50K | 50,000 |
| 2022-10-18 | Simon Mark Director | Purchase | +118,000 | $0.98 | $115K | 136,144 |
| 2022-10-18 | Simon Mark Director | Purchase | +7,000 | $0.98 | $7K | 7,000 |
| 2022-10-18 | Binder Gwendolyn See Remarks | Purchase | +20,000 | $0.99 | $20K | 20,000 |
| 2022-10-18 | Nichtberger Steven President & CEO | Purchase | +141,873 | $0.99 | $141K | 978,356 |
| 2022-06-01 | Brun Scott C. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-06-01 | Simon Mark Director | Grant or award · Stock Option (Right to buy) | +22,000 | 22,000 |
Page 10 of 13 · 256 trades